Andrew I. Koven
2016
In 2016, Andrew I. Koven earned a total compensation of $5.8M as President and Chief Business Officer at Aralez Pharmaceuticals, a 52% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $337,500 |
|---|---|
| Option Awards | $87,277 |
| Salary | $450,000 |
| Stock Awards | $686,557 |
| Other | $4,229,174 |
| Total | $5,790,508 |
Koven received $4.2M in other compensation, accounting for 73% of the total pay in 2016.
Koven also received $337.5K in non-equity incentive plan, $87.3K in option awards, $450K in salary and $686.6K in stock awards.
Rankings
In 2016, Andrew I. Koven's compensation ranked 1,290th out of 14,075 executives tracked by ExecPay. In other words, Koven earned more than 90.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,290 out of 14,075 | 91st |
Division Manufacturing | 433 out of 5,489 | 92nd |
Major group Chemicals And Allied Products | 114 out of 1,895 | 94th |
Industry group Drugs | 76 out of 1,538 | 95th |
Industry Pharmaceutical Preparations | 61 out of 1,176 | 95th |
Source: SEC filing on March 23, 2017.
Koven's colleagues
We found four more compensation records of executives who worked with Andrew I. Koven at Aralez Pharmaceuticals in 2016.